Carbamates of rapamycin
First Claim
1. A compound of the formula ##STR3## wherein R1 and R2 are each, independently, hydrogen or --CONH(CR3 R4)n --X;
- R3 and R4 are each, independently, hydrogen, alkyl of 1-6 carbon atoms, phenylalkyl of 7-10 carbon atoms, cycloalkyl of 3-8 carbon atoms, halogen, or trifluoromethyl;
X is hydrogen, lower alkyl of 1-6 carbon atoms, cycloalkyl of 3-8 carbon atoms, trifluoromethyl nitro, alkoxy of 1-6 carbon atoms, carboalkoxy of 2-7 carbon atoms, phenylalkyl of 7-10 carbon atoms, halo, dialkylamino of 1-6 carbon atoms per alkyl group, thioalkyl of 1-6 carbon atoms, or Y;
Y is a phenyl group which may be optionally mono-, di-, or tri-substituted with a group selected from alkyl of 1-6 carbon atoms, phenylalkyl of 7-10 carbon atoms, alkoxy of 1-6 carbon atoms, cyano, halo, nitro, carbalkoxy of 2-7 carbon atoms, trifluoromethyl, dialkylamino of 1-6 carbon atoms per alkyl group, or alkylthio of 1-6 carbon atoms;
n=0-5;
with the proviso that R1 and R2 are not both hydrogen and when n=0, X is lower alkyl of 1-6 carbon atoms, cycloalkyl of 3-8 carbon atoms, phenylalkyl of 7-10 carbon atoms, or Y;
or a pharmaceutically acceptable salt thereof when X is dialkylamino of 1-6 carbon atoms per alkyl group.
2 Assignments
0 Petitions
Accused Products
Abstract
A compound of the structure ##STR1## wherein R1 and R2 are each, independently, hydrogen or --CONH(CR3 R4)n --X;
R3 and R4 are each, independently, hydrogen, alkyl, aralkyl, cycloalkyl, halogen, or trifluoromethyl;
X ix hydrogen, lower alkyl, cycloalkyl, trifluoromethyl, nitro, alkoxy, carboalkoxy, aralkyl, halo, dialkylamino, thioalkyl, or Y;
Y is a phenyl group which may be optionally mono-, di-, or tri- substituted with a group selected from alkyl, aralkyl, alkoxy, cyano, halo, nitro, carbalkoxy, trifluoromethyl, dialkylamino, or alkylthio;
n=0-5;
with the proviso that R1 and R2 are not both hydrogen and when n=0, X is lower alkyl, cycloalkyl, aralkyl, or Y;
or a pharmaceutically acceptable salt thereof when X is dialkylamino, which by virtue of its immunosuppressive activity is useful in treating transplantation rejection, host vs. graft disease, autoimmune diseases and diseases of inflammation; by virtue of its antitumor activity is useful in treating solid tumors; and by virtue of its antifungal activity is useful in treating fungal infections.
269 Citations
23 Claims
-
1. A compound of the formula ##STR3## wherein R1 and R2 are each, independently, hydrogen or --CONH(CR3 R4)n --X;
-
R3 and R4 are each, independently, hydrogen, alkyl of 1-6 carbon atoms, phenylalkyl of 7-10 carbon atoms, cycloalkyl of 3-8 carbon atoms, halogen, or trifluoromethyl; X is hydrogen, lower alkyl of 1-6 carbon atoms, cycloalkyl of 3-8 carbon atoms, trifluoromethyl nitro, alkoxy of 1-6 carbon atoms, carboalkoxy of 2-7 carbon atoms, phenylalkyl of 7-10 carbon atoms, halo, dialkylamino of 1-6 carbon atoms per alkyl group, thioalkyl of 1-6 carbon atoms, or Y; Y is a phenyl group which may be optionally mono-, di-, or tri-substituted with a group selected from alkyl of 1-6 carbon atoms, phenylalkyl of 7-10 carbon atoms, alkoxy of 1-6 carbon atoms, cyano, halo, nitro, carbalkoxy of 2-7 carbon atoms, trifluoromethyl, dialkylamino of 1-6 carbon atoms per alkyl group, or alkylthio of 1-6 carbon atoms; n=0-5; with the proviso that R1 and R2 are not both hydrogen and when n=0, X is lower alkyl of 1-6 carbon atoms, cycloalkyl of 3-8 carbon atoms, phenylalkyl of 7-10 carbon atoms, or Y; or a pharmaceutically acceptable salt thereof when X is dialkylamino of 1-6 carbon atoms per alkyl group. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 22, 23)
-
-
20. A compound which is rapamycin-42-tert-butyldimethylsilyl ether-31-ester with (2,4-difluorophenyl)carbamic acid.
-
21. A method of treating transplantation rejection, host vs. draft disease, autoimmune diseases, and diseases of inflammation in a mammal by administering an effective amount of a compound having the formula ##STR4## wherein R1 and R2 are each, independently, hydrogen or --CONH(CR3 R4)n --X;
-
R3 and R4 are each, independently, hydrogen, alkyl of 1-6 carbon atoms, phenylalkyl of 7-10 carbon atoms, cycloalkyl of 3-8 carbon atoms, halogen, or trifluoromethyl; X is hydrogen, lower alkyl of 1-6 carbon atoms, cycloalkyl of 3-8 carbon atoms, trifluoromethyl nitro, alkoxy of 1-6 carbon atoms, carboalkoxy of 2-7 carbon atoms, phenylalkyl of 7-10 carbon atoms, halo, dialkylamino of 1-6 carbon atoms per alkyl group, thioalkyl of 1-6 carbon atoms, or Y; Y is a phenyl group which may be optionally mono-, di-, or tri-substituted with a group selected from alkyl of 1-6 carbon atoms, phenylalkyl of 7-10 carbon atoms, alkoxy of 1-6 carbon atoms, cyano, halo, nitro, carbalkoxy of 2-7 carbon atoms, trifluoromethyl, dialkylamino of 1-6 carbon atoms per alkyl group, or alkylthio of 1-6 carbon atoms; n=0-5; with the proviso that R1 and R2 are not both hydrogen and when n=0, X is lower alkyl of 1-6 carbon atoms, cycloalkyl of 3-8 carbon atoms, phenylalkyl of 7-10 carbon atoms, or Y; or a pharmaceutically acceptable salt thereof when X is dialkylamino of 1-6 carbon atoms per alkyl group.
-
Specification